home / stock / delcf / delcf news


DELCF News and Press, Delic Holdings From 01/28/22

Stock Information

Company Name: Delic Holdings
Stock Symbol: DELCF
Market: OTC
Website: deliccorp.com

Menu

DELCF DELCF Quote DELCF Short DELCF News DELCF Articles DELCF Message Board
Get DELCF Alerts

News, Short Squeeze, Breakout and More Instantly...

DELCF - Utah Bill Will Establish Task Force to Research Medical Use of Psychedelics

Representative Brady Brammer recently filed a measure that would establish a task force to investigate whether psychedelic substances should be used as a treatment option for post-traumatic stress disorder and other mental health conditions. In an interview last week, the Utah representative...

DELCF - Study Shows That Ketamine May Effectively Treat Alcohol Use Disorder

Awakn Life Sciences recently announced results from its double-blind, placebo-controlled trial, which is exploring the effectiveness of ketamine-assisted therapy in treating alcohol use disorder. The results show promise, offering hope for millions of individuals around the globe who suffe...

DELCF - New Measures Filed in Virginia Could Decriminalize Psychedelics

Last week, legislators in the state of Virginia introduced new measures to decriminalize the possession of psychedelic substances. The bills in the Senate and the House of Delegates are almost identical , except that the proposal in the latter covers a number of psychedelic substances whi...

DELCF - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Reports Findings of Commissioned Study Showing a Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment for Select Mental Conditions

The Harris Poll conducted a survey on behalf of Delic Holdings, polling 2,037 adults ages 18 and older, 953 of whom suffer from anxiety/depression/PTSD The survey revealed that 65% of Americans living with anxiety/depression/PTSD believe that psychedelic medicine should be available to ...

DELCF - PsychedelicNewsBreaks - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Expanding Access of New Medicines, Treatment for Mental Health Conditions

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, recently announced its wholly owned ketamine infusion clinic chain, Ketamine Wellness Centers LLC (“KWC”), will open two new clinics in Salt Lake City, Utah, and Reno, Nevada, by February 20...

DELCF - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Corporate Update Points to Profitability in 2022 and Beyond

In 2021, Delic’s investments and acquisitions allowed for an annualized revenue run-rate of over $9MM Going into the new year, the company looks forward to opening additional ketamine infusion treatment clinics, growing them by 15 within the next 18 months Delic’s growth...

DELCF - Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Attended This Year's H.C. Wainwright Bioconnect Virtual Conference

Delic Holdings Corp is a leader in new medicines and treatments for a modern world, with a business network which includes psychedelic wellness clinics, a licensed psilocybin research lab, a famed psychedelic wellness event, and dedicated media platforms The company announced that its c...

DELCF - Washington State Bill Seeks to Legalize Medical Use of Psilocybin

Last week, two legislators from Washington State introduced a proposal that would legalize psilocybin services in the state. The bill, dubbed SB5660 , would permit individuals aged 21 and above to consume products that contain psilocin and psilocybin under the supervision of a state-license...

DELCF - InvestorNewsBreaks - Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Releases Results of Harris Survey on Psychedelics as an Alternative Treatment

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has announced that nearly two-thirds (65%) of Americans who suffer from anxiety, depression and PTSD believe that psychedelic medicine, including ketamine, psilocybin and MDMA...

DELCF - Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address Anxiety, Depression and PTSD

Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address Anxiety, Depression and PTSD Canada NewsWire VANCOUVER, BC , Jan. 18, 2022 /CNW/ - A new survey conducted by The Harris Poll on behalf of Delic Holdings...

Previous 10 Next 10